Published in Drug Des Devel Ther on October 25, 2016
CYP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis. JAMA (2011) 5.93
Low-dose aspirin for secondary cardiovascular prevention - cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation - review and meta-analysis. J Intern Med (2005) 2.98
Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation (2007) 2.30
Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol. J Pharmacol Exp Ther (2006) 1.40
Pharmacokinetics of clopidogrel. Semin Thromb Hemost (1999) 1.03
Pharmacokinetics of acetylsalicylic acid and its metabolites at low doses: a compartmental modeling. Methods Find Exp Clin Pharmacol (1995) 0.98
Clopidogrel: a review of its use in the prevention of atherothrombosis. Drugs (2000) 0.97
Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers. J Clin Pharmacol (1995) 0.96
An appraisal of dual antiplatelet therapy with clopidogrel and aspirin for prevention of cardiovascular events. J Am Board Fam Med (2009) 0.92
Cigarette smoking and clopidogrel interaction. Curr Cardiol Rep (2013) 0.91
Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis. Cerebrovasc Dis (2014) 0.89
Determination of acetylsalicylic acid and its major metabolite, salicylic acid, in human plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study of Astrix in Korean healthy volunteers. Biomed Chromatogr (2008) 0.84
Formation of the thiol conjugates and active metabolite of clopidogrel by human liver microsomes. Mol Pharmacol (2012) 0.83
The economics of polypharmacology: fixed dose combinations and drug cocktails. Curr Med Chem (2013) 0.82
Fixed-dose aspirin-clopidogrel combination enhances compliance to aspirin after acute coronary syndrome. Int J Cardiol (2014) 0.80
The Antiplatelet Effect of Clopidogrel Decreases With Patient Age. Angiology (2016) 0.79
Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention. Heart (2016) 0.79